Europe
-
T cells point to new viral vaccines
Patients who have recovered from COVID-19 infection may benefit from strong T cell immunity – and even victims of the common cold may enjoy some immunity, according to a significant new study. Read more
-
Vaccines showing promise – but is cholesterol drug the key?
The UK’s Oxford vaccine project is showing promising results in its early stages of human testing, it was reported today. Read more
-
Shame and sorrow as UK’s clinician deaths topped only by Russia
The UK has suffered one of the highest loss rates of health and social care workers from the COVID-19 virus, according to a major global report published today. Read more
-
Healthy diet linked to reduced diabetes risk
Eating a diet with generous portions of fruit, vegetables and whole grain foods is associated with a lower risk of developing type 2 diabetes, according to two studies published today. Read more
-
Hope for new motor neuron disease therapy
Interleukin-2 is a potential treatment for amyotrophic lateral sclerosis, or ALS, also known as motor neuron disease, French researchers have reported. Read more
-
IVF rate of cerebral palsy falling
New figures suggest that the rate of cerebral palsy among children conceived by in vitro fertilisation has fallen by over half in the last 20 years. Read more
-
Could an anaemia drug help COVID-19 patients?
Scientists are investigating whether a common anaemia drug, erythropoietin, could become an effective treatment for COVID-19. Read more
-
Genetic variant behind cause of adult deafness
Thousands of adults are at risk of deafness because of a common inherited genetic variant, researchers report today. Read more
-
Hair test could revolutionise IVF
A single hair might provide a test for women seeking information about their fertility, an on-line conference was set to hear today. Read more
-
Major weaknesses’ in COVID-19 antibody tests
The COVID-19 antibody tests have major weaknesses, according to a review of the latest international research published today. Read more